Active Biotech AB (0GQU)
LSE
Closed
Sep 25, 2026
Day's Range
4.2552 wk Range
0.0381Overview - 0GQU - Active Biotech AB
Key Statistics
Valuation
Enterprise Value
68.23M
Price / Book
‪3.01‬
EV / EBITDA
‪-2.09‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-60.37%‬
Return on Equity
‪-140.55%‬
Ownership
Shares Outstanding
145.23M
Float
20.47M
Held by Insiders
‪16.98%‬
Held by Institutions
‪6.22%‬
Price stats
Beta
‪1.39‬
Market Cap - 0GQU - Active Biotech AB
Peers - 0GQU - Active Biotech AB
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0GQULSEActive Biotech AB792.98MMarket Cap+96.20%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- 0MGBLSEGenmab A/S198.39BMarket Cap+15.12%52-week change33.69P/E (Trailing)‪29.01%‬Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated Common Stock128.96BMarket Cap+20.00%52-week change0.53P/E (Trailing)‪34.99%‬Profit Margin
- 0A45LSEModerna Inc.95.05BMarket Cap+87.31%52-week change72.95P/E (Trailing)‪11.32%‬Profit Margin
- 0R2MLSERegeneron Pharmaceuticals, Inc.79.08BMarket Cap+20.99%52-week change0.11P/E (Trailing)‪27.86%‬Profit Margin
- 0QW0LSEargenx SE49.68BMarket Cap+27.60%52-week change40.07P/E (Trailing)‪-47.51%‬Profit Margin
- 0NZTLSEUCB SA41.70BMarket Cap-23.88%52-week change120.47P/E (Trailing)‪6.45%‬Profit Margin
Profile Summary - 0GQU - Active Biotech AB
About
Active Biotech AB is a Swedish biotechnology company focused on developing pharmaceutical products that modulate the immune system. Headquartered in Lund and founded in 1983, the company concentrates on treatments for cancer and inflammatory diseases, particularly inflammatory eye disorders. Its current portfolio…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
